HbA1c Testing Market to Reach USD 3.4 Billion by 2034

Pune, India, November 2025 - According to the latest report by Exactitude Consultancy, the Global HbA1c Testing Market is valued at USD 2.2 billion in 2024 and is projected to reach USD 3.4 billion by 2034, growing at a CAGR of 4.4% from 2025 to 2034. The market is witnessing robust growth due to increasing diabetes cases, technological advancements in testing devices, and the growing adoption of rapid and point-of-care (POC) HbA1c analyzers across hospitals, clinics, and homecare settings.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/49865

Key Takeaways
• Market Size (2024): USD 2.2 Billion
• Forecast (2034): USD 3.4 Billion
• CAGR (2025-2034): 4.4%
• Key Growth Drivers: Increasing diabetes incidence, early diagnosis programs, and integration of connected digital testing devices.
• Leading Companies: Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Bio-Rad Laboratories Inc., Tosoh Corporation, ARKRAY Inc., Danaher Corporation, and Trividia Health Inc.

Market Story
The HbA1c (Hemoglobin A1c) Testing Market is a cornerstone of diabetes management, measuring average blood glucose levels over three months. The test is vital for early diagnosis, treatment monitoring, and therapy optimization for both Type 1 and Type 2 diabetes.
Global diabetes prevalence continues to rise due to changing lifestyles, obesity, and aging populations, especially in emerging economies. This trend has increased the demand for accurate, rapid, and portable HbA1c testing systems capable of functioning in diverse clinical and home-based environments.

Recent advancements include automated high-performance liquid chromatography (HPLC), immunoassay-based devices, and AI-driven analytics integrated with electronic health records (EHRs). These technologies are improving diagnostic precision and enabling real-time data sharing for better patient outcomes. Additionally, home-based testing kits and POC analyzers are expanding access to diabetes screening and monitoring in underserved areas.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/49865/hba1c-testing-market

Market Segmentation
By Product Type:
• Instruments
• Reagents & Kits

By Technology:
• Ion-Exchange HPLC
• Immunoassay
• Boronate Affinity Chromatography
• Enzymatic Assay
• Other Methods

By End-User:
• Hospitals
• Diagnostic Laboratories
• Homecare Settings
• Research & Academic Institutes

By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Recent Developments
• 2025: Abbott launched a connected HbA1c analyzer integrated with cloud-based diabetes management software for primary care providers.
• 2024: Roche Diagnostics introduced a fully automated benchtop analyzer enabling multi-parameter diabetes screening in under 5 minutes.
• 2024: Bio-Rad Laboratories unveiled advanced HPLC-based analyzers with improved reagent stability for developing markets.
• 2023: Tosoh Corporation expanded its distribution of immunoassay-based HbA1c testing systems across Asia-Pacific to support mass diabetes screening.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49865

Expert Insight
"As diabetes cases rise globally, accessibility and accuracy in HbA1c testing are becoming public health priorities," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.
"Integration of AI-based analysis, portable testing, and telehealth platforms will revolutionize how diabetes monitoring is performed in both developed and emerging markets."

Regional Outlook
• North America dominates with over 38% market share, supported by advanced healthcare infrastructure and strong diabetes screening programs.
• Europe follows with increased adoption of POC testing and integrated lab automation systems.
• Asia Pacific is expected to record the highest growth (CAGR above 5.6%) due to rising diabetes prevalence in India and China, combined with expanding healthcare access.
• Latin America & Middle East show steady growth as awareness campaigns and affordable testing solutions improve diagnostic penetration.

Conclusion
The HbA1c Testing Market is entering a new era of digital diagnostics and personalized care, driven by advances in POC technologies, automation, and data connectivity. As global diabetes management shifts toward prevention and precision monitoring, HbA1c testing will remain the foundation for effective disease control strategies worldwide.

This report is also available in the following languages : Japanese (Hba1C検査市場), Korean (Hba1C 테스트 시장), Chinese (HbA1C检测市场), French (Marché des tests HbA1c), German (Markt für HbA1c-Tests), and Italian (Mercato dei test Hba1C), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/49865

Our More Reports:

Nuclear Imaging Devices Market
https://exactitudeconsultancy.com/reports/49316/nuclear-imaging-devices-market

Urinary Drainage Bags Market
https://exactitudeconsultancy.com/reports/49321/urinary-drainage-bags-market

Oral Cancer Diagnostics Market
https://exactitudeconsultancy.com/reports/49323/oral-cancer-diagnostics-market

Uveitis Treatment Market
https://exactitudeconsultancy.com/reports/49855/uveitis-treatment-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.